A new prediction tool combining patient age, autoimmune disease history, and blood cell measurements can identify MacroB12 interference—a condition where a sticky form of B12 tricks standard blood tests—with 80% accuracy in people with very high B12 levels. However, a special confirmatory test called PEG precipitation remains essential for definitive diagnosis, particularly in older patients and those with autoimmune disease.
Doctors sometimes get confused when blood tests show very high B12 levels, because a special type of B12 called MacroB12 can trick the test into giving false readings. Researchers studied 875 people with unusually high B12 levels to figure out who might have this problem. According to Gram Research analysis, they found that older people and those with autoimmune diseases were more likely to have MacroB12 interference. A combination of patient information and lab results helped predict this problem better than B12 levels alone, but doctors still need a special confirmatory test to be sure.
Key Statistics
A 2026 research analysis of 875 people with very high B12 levels found that patients with autoimmune diseases were nearly 3 times more likely to have MacroB12 interference (adjusted odds ratio 2.96, P=0.01).
According to research reviewed by Gram, combining clinical features with B12 levels improved prediction accuracy to 80% (AUC 0.802) compared to 74% using B12 levels alone in 875 patients with hypercobalaminemia.
A 2026 study of 875 patients identified an optimal B12 threshold of 1584 pg/mL for suspecting MacroB12 interference, with 71% sensitivity and 70% specificity, but confirmed that confirmatory testing remains essential.
Research showed that for every additional year of age, the odds of MacroB12 interference increased by 3% (adjusted odds ratio 1.03 per year, P<0.001) in 875 patients with high B12 levels.
The Quick Take
- What they studied: Can doctors predict when MacroB12 (a fake type of B12) is interfering with blood test results that show very high B12 levels?
- Who participated: 875 people with blood B12 levels above 1000 pg/mL (much higher than normal), analyzed using medical records from 2026
- Key finding: A combination of patient age, autoimmune disease history, and specific blood cell measurements predicted MacroB12 interference better than B12 levels alone (78% accuracy versus 74% accuracy)
- What it means for you: If you have very high B12 results and are older or have an autoimmune condition, your doctor may want to do additional testing to confirm whether you truly have high B12 or if MacroB12 is causing a false reading. This helps avoid missing real B12 deficiency.
The Research Details
Researchers looked back at medical records from 875 people who had blood B12 levels above 1000 pg/mL (the normal range is 200-900 pg/mL). They used a special lab technique called PEG precipitation to identify which patients had MacroB12 interference—a situation where a sticky form of B12 attaches to proteins and tricks standard blood tests.
They then used statistical methods to find patterns: which patient characteristics and lab results best predicted MacroB12 interference. They tested whether B12 levels alone could predict the problem, then added other information like age, medical history, and blood cell counts to see if predictions improved.
The researchers used a mathematical approach called multivariable regression, which is like finding the best combination of clues to solve a puzzle. They also created a scoring system to help doctors decide which patients need the special confirmatory test.
MacroB12 interference is a real diagnostic problem that can hide true B12 deficiency or create false alarms about high B12. Having a prediction tool helps doctors know when to order the special confirmatory test, saving time and preventing misdiagnosis. This is especially important for older patients and those with autoimmune diseases, who appear more likely to have this problem.
This study has good strengths: a large sample size (875 people), use of statistical methods to handle missing data, and testing on a real hospital lab system (Abbott Alinity i). However, the study only looked at one type of lab equipment, so results may not apply to other brands. The moderate accuracy (78%) means the prediction tool helps but cannot replace the definitive confirmatory test. The study was retrospective (looking backward at records), which is less powerful than a prospective study (following patients forward).
What the Results Show
The researchers found that MacroB12 interference was more common in older patients and those with autoimmune or rheumatologic diseases. For every additional year of age, the odds of having MacroB12 increased by 3% (adjusted odds ratio 1.03). Patients with autoimmune diagnoses were nearly 3 times more likely to have MacroB12 interference (adjusted odds ratio 2.96).
Interestingly, patients with MacroB12 also tended to have higher hemoglobin (the protein that carries oxygen in blood) and larger red blood cells than expected. This counterintuitive finding suggests MacroB12 creates a distinctive pattern that doctors can recognize.
When doctors used just the B12 blood level to predict MacroB12, they were correct about 74% of the time. But when they combined B12 levels with patient age, autoimmune disease status, and blood cell measurements, accuracy improved to 80%. The optimal B12 threshold for suspicion was 1584 pg/mL, which correctly identified 71% of MacroB12 cases while avoiding false alarms in 70% of cases without MacroB12.
The study identified a clinical pattern or ‘phenotype’ for suspected MacroB12: older age, autoimmune disease history, and specific blood cell changes. This pattern helps doctors recognize which patients need further testing. The research also confirmed that B12 levels alone cannot reliably distinguish true high B12 from MacroB12 interference, supporting the need for confirmatory testing in suspicious cases.
Previous research recognized that MacroB12 exists and can interfere with B12 testing, but this study is among the first to systematically predict who has it using a combination of clinical and laboratory features. The moderate accuracy (80%) is consistent with the complexity of B12 metabolism and suggests that MacroB12 interference is not a simple, easily predicted phenomenon. This aligns with clinical experience that MacroB12 is a real but somewhat unpredictable problem.
The study only looked at people with very high B12 levels (above 1000 pg/mL), so results may not apply to people with normal or low B12. The research used only one brand of lab equipment (Abbott Alinity i), so the prediction tool may work differently on other machines. The study looked backward at old records rather than following patients forward, which is less reliable. The 80% accuracy means the prediction tool is helpful but not perfect—doctors still need the special confirmatory test to be certain. Finally, the study didn’t explain why autoimmune disease and MacroB12 are connected, leaving that question for future research.
The Bottom Line
If your B12 blood test shows a very high level (above 1584 pg/mL) and you are older or have an autoimmune disease, ask your doctor about getting a confirmatory test for MacroB12 interference. This is a moderate-confidence recommendation based on one study. The special PEG precipitation test remains the gold standard for confirming MacroB12. Do not assume high B12 results are accurate without this confirmation, especially if you have symptoms of B12 deficiency.
This research matters most for older adults, people with autoimmune diseases (like rheumatoid arthritis or lupus), and their doctors. Laboratory professionals and hospital systems using Abbott Alinity equipment should pay attention. People with normal or low B12 levels do not need to worry about MacroB12 interference. Healthy young people without autoimmune disease have lower risk.
If MacroB12 interference is confirmed, the timeline depends on the underlying cause. Addressing any autoimmune disease or other conditions may help normalize B12 metabolism over weeks to months. The confirmatory test itself takes days to a week for results.
Frequently Asked Questions
What is MacroB12 and why does it matter for B12 testing?
MacroB12 is a sticky form of B12 that attaches to proteins in blood and tricks standard lab tests into showing falsely high B12 levels. This can hide real B12 deficiency or create false alarms, making accurate diagnosis difficult. A special PEG precipitation test can confirm whether MacroB12 is present.
Who is most likely to have MacroB12 interference?
Older adults and people with autoimmune diseases (like rheumatoid arthritis or lupus) are significantly more likely to have MacroB12 interference. A 2026 study of 875 patients found autoimmune disease increased risk nearly 3-fold and each year of age increased risk by 3%.
Can my doctor tell if I have MacroB12 just from my B12 blood level?
Not reliably. While a B12 level above 1584 pg/mL raises suspicion, especially with autoimmune disease or older age, the prediction tool is only 80% accurate. Your doctor needs the special PEG precipitation confirmatory test to be certain whether MacroB12 is interfering with your results.
What should I do if my B12 test shows a very high level?
Ask your doctor whether a confirmatory PEG precipitation test is needed, especially if you’re older or have an autoimmune disease. Don’t assume the high result is accurate without this confirmation, particularly if you have B12 deficiency symptoms like fatigue or numbness.
Does this research apply to all lab equipment and hospitals?
This study used only one brand of lab equipment (Abbott Alinity i), so results may differ on other machines. Doctors and hospitals should validate these findings on their own equipment before using the prediction tool clinically. The confirmatory PEG test remains reliable across all systems.
Want to Apply This Research?
- Track your B12 blood test results and dates, noting whether confirmatory PEG testing was done and the result. Record any autoimmune disease diagnoses and your age to help identify your personal risk profile for MacroB12 interference.
- If you have high B12 results and risk factors (older age or autoimmune disease), request the PEG precipitation confirmatory test from your doctor rather than assuming the initial result is accurate. Keep a record of all B12 testing to show patterns over time.
- If MacroB12 interference is confirmed, work with your doctor to monitor B12 status using alternative methods beyond standard blood tests. Track any B12 deficiency symptoms (fatigue, numbness, cognitive changes) and repeat confirmatory testing annually or as recommended by your healthcare provider.
This research describes a prediction tool for MacroB12 interference but does not replace medical diagnosis or treatment. If you have high B12 blood test results, especially with symptoms of B12 deficiency or if you have an autoimmune disease or are older, consult your healthcare provider about whether confirmatory PEG precipitation testing is appropriate. Do not self-diagnose or change B12 supplementation based on this information alone. This study was conducted on one brand of lab equipment; results may not apply to all laboratory systems. Always work with your doctor to interpret your individual test results and determine appropriate follow-up testing.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.